Concepedia

Jon J. Hangeland

JJ

Statistics

Publications

12

Citations

513

H-Index

12

Active since

1990

Affiliations

Bristol-Myers Squibb (United States)(Current)

Karo Pharma (Sweden)

Johns Hopkins University

Bristol-Myers Squibb (Germany)

Jon J. Hangeland is an author at Bristol-Myers Squibb (United States) specializing in pharmacy, pharmacology, and medicinal chemistry.

Publications per year

1990–2019

12

Publications

12

Specific abstraction of the 5'S- and 4'-deoxyribosyl hydrogen atoms from DNA by calicheamicin .gamma.1I

Jon J. Hangeland, James J. De Voss, Julie A. Heath et al. · Journal of the American Chemical Society · 1992 · 111 citations

Pharmacy, Biochemistry, Chemistry +10

Characterization of the in vitro cyclization chemistry of calicheamicin and its relation to DNA cleavage

James J. De Voss, Jon J. Hangeland, Craig A. Townsend · Journal of the American Chemical Society · 1990 · 75 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +5

Cell-Type Specific and Ligand Specific Enhancement of Cellular Uptake of Oligodeoxynucleoside Methylphosphonates Covalently Linked with a Neoglycopeptide, YEE(ah-GalNAc)3

Jon J. Hangeland, Joel T. Levis, Yuan C. Lee et al. · Bioconjugate Chemistry · 1995 · 63 citations

Medicine, Biochemistry, Pharmacology +14

Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta

Jon J. Hangeland, Arthur M. Doweyko, Tamara Dejneka et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

Pharmacy, Endocrinology, Medicinal Chemistry +14

Tissue Distribution and Metabolism of the [ <sup>32</sup> P]-Labeled Oligodeoxynucleoside Methylphosphonate-Neoglycopeptide Conjugate, [YEE(ah-GalNAc) <sub>3</sub> ]-SMCC-AET-pU <sup>m</sup> p <u>T</u> <sub>7</sub> , in the Mouse

Jon J. Hangeland, John E. Flesher, Scott F. Deamond et al. · Antisense and Nucleic Acid Drug Development · 1997 · 44 citations

Pharmacy, Molecular Biology, Pharmacology +17

1–5 of 12